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In this special issue, we have 9 articles that highlight diverse
biochemical, immunological, molecular, and neuroimaging
techniques used to decipher the pathophysiological mech-
anisms underpinning neurodegeneration in various cellular
and animal models. The common diseases are covered,
including a review on the therapeutic options in Alzheimer’s
disease and a discussion on the factors influencing homo-
cysteine levels in Parkinson’s disease. Of particular interest
in this issue is an article on the entity of “chemo brain,”
a condition that overlaps between oncology and neurology.
“Chemo brain” is a common term used to describe thinking
and memory problems that can occur after cancer treatment.
Here the authors demonstrate PET evidence of the effect
of donepezil on cognitive performance in an animal model.
We hope this special issue will generate further interest and
debate on the pathoetiology of neurodegenerative diseases
and provide a platform to generate impetus to further identify
and validate new therapeutic options.
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